Abstract:It is believed that microcirculation dysfunction in sepsis primarily caused by damage of the endothelium by infectious agents and pro-inflammatory cytokines. Mechanisms of impaired microcirculation in the severe course of COVID-19 and sepsis likely to be similar. However, there are few reports studied microcirculation disorders in patients with COVID-19, and their results are sometimes contradictory. Objective. To assess the microcirculation of patients with severe Covid-19 and the development of bacterial sepsis using nail bed microscopy and laser Doppler flowmetry. Materials and methods. 16 intensive care unit COVID-19 patients subsequently diagnosed with bacterial sepsis were examined. Patients underwent vital capillaroscopy and an occlusive test using laser Doppler flowmetry. The average rate of capillary blood flow, the size of the perivascular zone, the density of capillaries, the presence of intravascular aggregates, the increase in the amplitude of the maximum post-occlusive blood flow and the average value of postocclusive blood flow relative to the initial one were valuated. Additionally, the level of serum proadrenomedullin was evaluated. Studies were performed on the day of admission and in dynamics. Results. By the capillaroscopy analysis, microcirculation disorders were detected in the form of a decrease in the linear speed of capillary blood flow ( 100 μm), the circulation of microaggregates; the absence of postocclusive hyperemia was determined by an occlusive test. Secondary bacterial infection led to an even greater aggravation of microcirculation disorders: an increase of the perivascular zone, the progression of intravascular aggregation resulting in microthrombosis with a decrease of the density of the capillary network (according to capillaroscopy), as well as a sharp decrease of amplitude maximal increment of blood flow of post-осclusive circulation at the time of an occlusive sample. We also revealed a trend of negative correlation between the level of serum proadrenomedullin and the maximum increase in blood flow during the occlusive test. Conclusion. The secondary bacterial infection in patients with COVID-19 leads to a significant aggravation of microcirculation disorders with the development of perfusion deficiency and interstitial edema. The increased plasma proadrenomedullin level supports the concept of the significant role of endothelial dysfunction in the pathogenesis of severe COVID-10 and bacterial sepsis.

In vivo demonstration of microvascular thrombosis in severe COVID-19

Hemorrhage and Venous Thromboembolism in Critically Ill Patients with COVID-19

Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus

Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment

Microcirculatory Alterations in Critically Ill Patients with COVID-19-Associated Acute Respiratory Distress Syndrome

Endothelial Dysfunction and Thrombosis in Patients With COVID-19—Brief Report

Detection and Quantification of Microcirculatory Dysfunction in Severe COVID-19 Not Requiring Mechanical Ventilation: A Three-Arm Cohort Study

Large and Small Cerebral Vessel Involvement in Severe COVID-19: Detailed Clinical Workup of a Case Series

Left ventricular mural thrombi with multisystem thrombosis in patients with COVID-19 and myocardial injury: a case series

Microcirculation disorders in patients with severe COVID-19 and development of bacterial sepsis

Susceptibility-weighted imaging reveals cerebral microvascular injury in severe COVID-19

Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases

Observational study of thrombosis and bleeding in COVID-19 VV ECMO patients

Vascular Manifestations of COVID-19 – Thromboembolism and Microvascular Dysfunction

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy

Microvascular Dysfunction in COVID-19 Patients with Acute Coronary Syndrome

From dermatological conditions to COVID-19: Reasoning for anticoagulation, suppression of inflammation, and hyperbaric oxygen therapy

The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications

Coronary microthrombi in the failing human heart: the role of von Willebrand factor and PECAM-1

COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management

COVID-19 and thrombosis: The role of hemodynamics